Rooney CM - Search Results

1

Eighteen-year survival after GD2-directed Chimeric Antigen Receptor-Modified Immune Effector Cell Treatment for Neuroblastoma.

Che-Hsing L, Sharma S, Heczey AA, Steffin DHM, Louis CU, Grilley BJ, Thakkar SG, Wu M, Wang T, Rooney CM, Brenner MK, Heslop HE. Che-Hsing L, et al. Among authors: rooney cm. Res Sq [Preprint]. 2024 Apr 11:rs.3.rs-4232549. doi: 10.21203/rs.3.rs-4232549/v1. Res Sq. 2024. PMID: 38659815 Free PMC article. Preprint.

2

Production of genetically modified Epstein-Barr virus-specific cytotoxic T cells for adoptive transfer to patients at high risk of EBV-associated lymphoproliferative disease.

Smith CA, Ng CY, Heslop HE, Holladay MS, Richardson S, Turner EV, Loftin SK, Li C, Brenner MK, Rooney CM. Smith CA, et al. Among authors: rooney cm. J Hematother. 1995 Apr;4(2):73-9. doi: 10.1089/scd.1.1995.4.73. J Hematother. 1995. PMID: 7633844

3

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation.

Rooney CM, Smith CA, Ng CY, Loftin S, Li C, Krance RA, Brenner MK, Heslop HE. Rooney CM, et al. Lancet. 1995 Jan 7;345(8941):9-13. doi: 10.1016/s0140-6736(95)91150-2. Lancet. 1995. PMID: 7799740

4

Donor T cells to treat EBV-associated lymphoma.

Heslop HE, Brenner MK, Rooney CM. Heslop HE, et al. Among authors: rooney cm. N Engl J Med. 1994 Sep 8;331(10):679-80. doi: 10.1056/NEJM199409083311017. N Engl J Med. 1994. PMID: 8052285 No abstract available.

5

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes.

Heslop HE, Ng CY, Li C, Smith CA, Loftin SK, Krance RA, Brenner MK, Rooney CM. Heslop HE, et al. Among authors: rooney cm. Nat Med. 1996 May;2(5):551-5. doi: 10.1038/nm0596-551. Nat Med. 1996. PMID: 8616714

6

Use of gene marking in bone marrow transplantation.

Heslop HE, Rooney CM, Rill DR, Krance RA, Brenner MK. Heslop HE, et al. Among authors: rooney cm. Cancer Detect Prev. 1996;20(2):108-13. Cancer Detect Prev. 1996. PMID: 8706035

7

Gene-marking and haemopoietic stem-cell transplantation.

Heslop HE, Rooney CM, Brenner MK. Heslop HE, et al. Among authors: rooney cm. Blood Rev. 1995 Dec;9(4):220-5. doi: 10.1016/s0268-960x(95)90013-6. Blood Rev. 1995. PMID: 8839397 Review.

8

Control of virus-induced lymphoproliferation: Epstein-Barr virus-induced lymphoproliferation and host immunity.

Rooney CM, Smith CA, Heslop HE. Rooney CM, et al. Mol Med Today. 1997 Jan;3(1):24-30. doi: 10.1016/S1357-4310(96)10054-X. Mol Med Today. 1997. PMID: 9021739 Review.

9

Adoptive immunotherapy for Epstein-Barr virus-related lymphoma.

Smith CA, Ng CY, Loftin SK, Li C, Heslop HE, Brenner MK, Rooney CM. Smith CA, et al. Among authors: rooney cm. Leuk Lymphoma. 1996 Oct;23(3-4):213-20. doi: 10.3109/10428199609054823. Leuk Lymphoma. 1996. PMID: 9031101 Review.

10

Adoptive cellular immunotherapy for EBV lymphoproliferative disease.

Heslop HE, Rooney CM. Heslop HE, et al. Among authors: rooney cm. Immunol Rev. 1997 Jun;157:217-22. doi: 10.1111/j.1600-065x.1997.tb00984.x. Immunol Rev. 1997. PMID: 9255632 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

312 results

Search Page